Skip to main content

PDS Biotechnology Corp

PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472091

No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding PDS Biotechnology Corp changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of PDSB: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders47244−1
Shares5.62M62.0K7.88M+2.32M (+41.8%)
Value$5.32M$62.6K$6.07M+$806.2K (+15.3%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held PDS Biotechnology Corp at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to PDSB in Q4 2025
InstitutionSharesValue% of portfolio
Armistice Capital, LLC2,834,506$2.18M0.05%
Virtu Financial LLC32,099$25.0K0.00%
ACT Capital Management, LLC30,000$23.1K0.02%
StoneX Group Inc.16,000$12.3K0.00%
Ground Swell Capital, LLC14,703$11.3K0.02%
Wealth Group, Ltd.13,399$10.0K0.01%
Davenport & Co LLC10,000$7.70K0.00%
Group One Trading, L.P.3,922$3.02K0.00%
Tower Research Capital LLC (TRC)2,220$1.71K0.00%
Basecamp Wealth Advisors LLC377$2900.00%

Sold out (11)

Institutions that held PDS Biotechnology Corp at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of PDSB in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Citadel Advisors LLC386,430$390.3K
Acadian Asset Management LLC61,793$61.0K
Jane Street Group, LLC36,581$36.9K
Dimensional Fund Advisors LP18,382$18.6K
Two Sigma Securities, LLC14,149$14.3K
Mercer Global Advisors Inc12,500$12.6K
Stratos Wealth Partners, LTD.11,303$11.4K
Burns J W & Co Inc10,300$10.4K
Baader Bank INC10,528$6.57K
FMR LLC1,006$1.02K
Rialto Wealth Management, LLC400$404

Not filed for Q4 2025 yet (2)

Institutions that held PDS Biotechnology Corp at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PDSB in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Watts Gwilliam & Co., LLC55,000$55.5K
Kathleen S. Wright Associates Inc.7,000$7.07K